A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses2018-01-17T17:04:40-05:00
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes2018-01-17T17:03:07-05:00
